Mumbai: Maharashtra Chief Minister Eknath Shinde and Deputy Chief Minister Devendra Fadnavis inaugurated Phase 2A of Mumbai Metro Line 3 on Friday, marking a significant milestone in the city’s ...

Phase 3 of the Ireland/Ironwood intersection project begins. During this phase, work will focus on the center lanes of Ironwood Drive. That means left turns will be prohibited from all directions ...

These version 3.3 Phase 1 Banners start on Wednesday 21st May and are expected to end on Wednesday 11th June. These version 3.3 Phase 2 Banners are expected to run from Wednesday 11th June to ...

According to DOTD, motorists will see more changes this week. The I-20 project is in phase 3, meaning drivers are closer than ever to being able to drive on a resurfaced interstate. "So I-20 is ...

It’s been eight months since the Union government approved two corridors under Bengaluru Metro Phase 3 at an estimated cost of Rs 15,611 crore, but Bangalore Metro Rail Corporation Ltd (BMRCL ...

The former first daughter has two daughters, Mila and Poppy, and son Hal Jenna Bush Hager/Instagram Jenna Bush Hager enjoyed some quality family time this weekend. The daytime talk show host ...

Jenna Bush Hager enjoyed some quality family time this weekend. The daytime talk show host, 43, spent her Easter surrounded by the people who matter most in her life — her family. On Sunday ...

LAWRENCEVILLE, N.J., March 24, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that the U ...

The phase 3 OVATION 3 trial will evaluate IMNN-001's efficacy and safety in advanced ovarian cancer patients, comparing it with standard chemotherapy. Phase 2 results demonstrated a 35% improvement in ...

A phase 3 trial plans to evaluate Pro-ocular for the treatment of patients with ocular graft-vs-host disease. Signal12 Pharmaceuticals has aligned with the FDA on its phase 3 clinical trial strategy ...

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq: INCY) today announced positive topline results from its pivotal Phase 3 STOP-HS clinical trial program evaluating the safety and efficacy of ...

Results showed a greater percentage of povorcitinib-treated patients achieved HiSCR50 compared with placebo at week 12. Topline data were announced from two pivotal phase 3 studies evaluating ...